The Hague, Feb 16 (efe-epa).- Johnson & Johnson has formally submitted its Covid-19 vaccine for conditional marketing authorization in the European Union, the bloc’s medicines agency (EMA) said Tuesday.
The EMA said it will assess the vaccine under an accelerated timeline and could offer an opinion by mid-March. It would become the fourth vaccine to get EU approval after Pfizer-BioNTech, Moderna and AstraZeneca.
“EMA is now assessing additional data on the efficacy and safety of the vaccine as well as its quality,” an EMA statement read.
The application was submitted by Johnson & Johnson’s European affiliate Janssen-Cilag International.
The European Center for Disease Control on Monday said that while several EU nations were reporting a drop in Covid-19 cases, largely thanks to partial lockdowns and restrictions, the epidemiological situation and the spread of virulent new coronavirus variants remained causes for “concern.” EFE